Cargando…

High-Affinity Inhibitors of Human NAD(+)-Dependent 15-Hydroxyprostaglandin Dehydrogenase: Mechanisms of Inhibition and Structure-Activity Relationships

BACKGROUND: 15-hydroxyprostaglandin dehydrogenase (15-PGDH, EC 1.1.1.141) is the key enzyme for the inactivation of prostaglandins, regulating processes such as inflammation or proliferation. The anabolic pathways of prostaglandins, especially with respect to regulation of the cyclooxygenase (COX) e...

Descripción completa

Detalles Bibliográficos
Autores principales: Niesen, Frank H., Schultz, Lena, Jadhav, Ajit, Bhatia, Chitra, Guo, Kunde, Maloney, David J., Pilka, Ewa S., Wang, Minghua, Oppermann, Udo, Heightman, Tom D., Simeonov, Anton
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970562/
https://www.ncbi.nlm.nih.gov/pubmed/21072165
http://dx.doi.org/10.1371/journal.pone.0013719
_version_ 1782190471531986944
author Niesen, Frank H.
Schultz, Lena
Jadhav, Ajit
Bhatia, Chitra
Guo, Kunde
Maloney, David J.
Pilka, Ewa S.
Wang, Minghua
Oppermann, Udo
Heightman, Tom D.
Simeonov, Anton
author_facet Niesen, Frank H.
Schultz, Lena
Jadhav, Ajit
Bhatia, Chitra
Guo, Kunde
Maloney, David J.
Pilka, Ewa S.
Wang, Minghua
Oppermann, Udo
Heightman, Tom D.
Simeonov, Anton
author_sort Niesen, Frank H.
collection PubMed
description BACKGROUND: 15-hydroxyprostaglandin dehydrogenase (15-PGDH, EC 1.1.1.141) is the key enzyme for the inactivation of prostaglandins, regulating processes such as inflammation or proliferation. The anabolic pathways of prostaglandins, especially with respect to regulation of the cyclooxygenase (COX) enzymes have been studied in detail; however, little is known about downstream events including functional interaction of prostaglandin-processing and -metabolizing enzymes. High-affinity probes for 15-PGDH will, therefore, represent important tools for further studies. PRINCIPAL FINDINGS: To identify novel high-affinity inhibitors of 15-PGDH we performed a quantitative high-throughput screen (qHTS) by testing >160 thousand compounds in a concentration-response format and identified compounds that act as noncompetitive inhibitors as well as a competitive inhibitor, with nanomolar affinity. Both types of inhibitors caused strong thermal stabilization of the enzyme, with cofactor dependencies correlating with their mechanism of action. We solved the structure of human 15-PGDH and explored the binding modes of the inhibitors to the enzyme in silico. We found binding modes that are consistent with the observed mechanisms of action. CONCLUSIONS: Low cross-reactivity in screens of over 320 targets, including three other human dehydrogenases/reductases, suggest selectivity of the present inhibitors for 15-PGDH. The high potencies and different mechanisms of action of these chemotypes make them a useful set of complementary chemical probes for functional studies of prostaglandin-signaling pathways. ENHANCED VERSION: This article can also be viewed as an enhanced version in which the text of the article is integrated with interactive 3D representations and animated transitions. Please note that a web plugin is required to access this enhanced functionality. Instructions for the installation and use of the web plugin are available in Text S2.
format Text
id pubmed-2970562
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-29705622010-11-10 High-Affinity Inhibitors of Human NAD(+)-Dependent 15-Hydroxyprostaglandin Dehydrogenase: Mechanisms of Inhibition and Structure-Activity Relationships Niesen, Frank H. Schultz, Lena Jadhav, Ajit Bhatia, Chitra Guo, Kunde Maloney, David J. Pilka, Ewa S. Wang, Minghua Oppermann, Udo Heightman, Tom D. Simeonov, Anton PLoS One Research Article BACKGROUND: 15-hydroxyprostaglandin dehydrogenase (15-PGDH, EC 1.1.1.141) is the key enzyme for the inactivation of prostaglandins, regulating processes such as inflammation or proliferation. The anabolic pathways of prostaglandins, especially with respect to regulation of the cyclooxygenase (COX) enzymes have been studied in detail; however, little is known about downstream events including functional interaction of prostaglandin-processing and -metabolizing enzymes. High-affinity probes for 15-PGDH will, therefore, represent important tools for further studies. PRINCIPAL FINDINGS: To identify novel high-affinity inhibitors of 15-PGDH we performed a quantitative high-throughput screen (qHTS) by testing >160 thousand compounds in a concentration-response format and identified compounds that act as noncompetitive inhibitors as well as a competitive inhibitor, with nanomolar affinity. Both types of inhibitors caused strong thermal stabilization of the enzyme, with cofactor dependencies correlating with their mechanism of action. We solved the structure of human 15-PGDH and explored the binding modes of the inhibitors to the enzyme in silico. We found binding modes that are consistent with the observed mechanisms of action. CONCLUSIONS: Low cross-reactivity in screens of over 320 targets, including three other human dehydrogenases/reductases, suggest selectivity of the present inhibitors for 15-PGDH. The high potencies and different mechanisms of action of these chemotypes make them a useful set of complementary chemical probes for functional studies of prostaglandin-signaling pathways. ENHANCED VERSION: This article can also be viewed as an enhanced version in which the text of the article is integrated with interactive 3D representations and animated transitions. Please note that a web plugin is required to access this enhanced functionality. Instructions for the installation and use of the web plugin are available in Text S2. Public Library of Science 2010-11-02 /pmc/articles/PMC2970562/ /pubmed/21072165 http://dx.doi.org/10.1371/journal.pone.0013719 Text en This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
Niesen, Frank H.
Schultz, Lena
Jadhav, Ajit
Bhatia, Chitra
Guo, Kunde
Maloney, David J.
Pilka, Ewa S.
Wang, Minghua
Oppermann, Udo
Heightman, Tom D.
Simeonov, Anton
High-Affinity Inhibitors of Human NAD(+)-Dependent 15-Hydroxyprostaglandin Dehydrogenase: Mechanisms of Inhibition and Structure-Activity Relationships
title High-Affinity Inhibitors of Human NAD(+)-Dependent 15-Hydroxyprostaglandin Dehydrogenase: Mechanisms of Inhibition and Structure-Activity Relationships
title_full High-Affinity Inhibitors of Human NAD(+)-Dependent 15-Hydroxyprostaglandin Dehydrogenase: Mechanisms of Inhibition and Structure-Activity Relationships
title_fullStr High-Affinity Inhibitors of Human NAD(+)-Dependent 15-Hydroxyprostaglandin Dehydrogenase: Mechanisms of Inhibition and Structure-Activity Relationships
title_full_unstemmed High-Affinity Inhibitors of Human NAD(+)-Dependent 15-Hydroxyprostaglandin Dehydrogenase: Mechanisms of Inhibition and Structure-Activity Relationships
title_short High-Affinity Inhibitors of Human NAD(+)-Dependent 15-Hydroxyprostaglandin Dehydrogenase: Mechanisms of Inhibition and Structure-Activity Relationships
title_sort high-affinity inhibitors of human nad(+)-dependent 15-hydroxyprostaglandin dehydrogenase: mechanisms of inhibition and structure-activity relationships
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970562/
https://www.ncbi.nlm.nih.gov/pubmed/21072165
http://dx.doi.org/10.1371/journal.pone.0013719
work_keys_str_mv AT niesenfrankh highaffinityinhibitorsofhumannaddependent15hydroxyprostaglandindehydrogenasemechanismsofinhibitionandstructureactivityrelationships
AT schultzlena highaffinityinhibitorsofhumannaddependent15hydroxyprostaglandindehydrogenasemechanismsofinhibitionandstructureactivityrelationships
AT jadhavajit highaffinityinhibitorsofhumannaddependent15hydroxyprostaglandindehydrogenasemechanismsofinhibitionandstructureactivityrelationships
AT bhatiachitra highaffinityinhibitorsofhumannaddependent15hydroxyprostaglandindehydrogenasemechanismsofinhibitionandstructureactivityrelationships
AT guokunde highaffinityinhibitorsofhumannaddependent15hydroxyprostaglandindehydrogenasemechanismsofinhibitionandstructureactivityrelationships
AT maloneydavidj highaffinityinhibitorsofhumannaddependent15hydroxyprostaglandindehydrogenasemechanismsofinhibitionandstructureactivityrelationships
AT pilkaewas highaffinityinhibitorsofhumannaddependent15hydroxyprostaglandindehydrogenasemechanismsofinhibitionandstructureactivityrelationships
AT wangminghua highaffinityinhibitorsofhumannaddependent15hydroxyprostaglandindehydrogenasemechanismsofinhibitionandstructureactivityrelationships
AT oppermannudo highaffinityinhibitorsofhumannaddependent15hydroxyprostaglandindehydrogenasemechanismsofinhibitionandstructureactivityrelationships
AT heightmantomd highaffinityinhibitorsofhumannaddependent15hydroxyprostaglandindehydrogenasemechanismsofinhibitionandstructureactivityrelationships
AT simeonovanton highaffinityinhibitorsofhumannaddependent15hydroxyprostaglandindehydrogenasemechanismsofinhibitionandstructureactivityrelationships